Moreover, high FGF-23 levels have been associated with multiple adverse cardiovascular outcomes, including hypertension, left ventricular hypertrophy, subclinical atherosclerosis and cardiovascular events, and mortality [4]. Here, FGF23 is linked to atherosclerosis.